Skip to main content
Premium Trial:

Request an Annual Quote

Abbott's MDx Sales Drop 2 Percent in Q2

NEW YORK (GenomeWeb) – Abbott today reported that its diagnostics sales jumped 5 percent year over year in the second quarter, but molecular diagnostics was a drag on the business, falling 2 percent.

The medical products giant reported total revenues of $5.55 billion for the quarter ended June 30, up 2 percent from $5.45 billion for Q2 2013.

Its diagnostics business recorded $1.19 billion in revenues for the quarter, up around 5 percent from $1.14 billion in Q2 2013. Its core laboratory diagnostics sales increased 6 percent year over year to $968 million, while its point-of-care diagnostics sales were up roughly 4 percent at $105 million.

Its molecular diagnostics sales, however, declined to $116 million from $119 million. Abbott said the decrease was due to the "timing of tenders in the infectious disease business in several emerging markets, which are expected to drive higher growth in the second half of 2014."

Abbott reported Q2 net earnings of $466 million, or $.30 per share, compared to $476 million, or $.30 per share, for Q2 2013. Its EPS from continuing operations increased to $.54 from $.46.

The firm raised its FY 2014 ongoing EPS guidance to a range of $2.19 to $2.29 from an earlier range of $2.16 to $2.26.

The Scan

Study Finds Sorghum Genetic Loci Influencing Composition, Function of Human Gut Microbes

Focusing on microbes found in the human gut microbiome, researchers in Nature Communications identified 10 sorghum loci that appear to influence the microbial taxa or microbial metabolite features.

Treatment Costs May Not Coincide With R&D Investment, Study Suggests

Researchers in JAMA Network Open did not find an association between ultimate treatment costs and investments in a drug when they analyzed available data on 60 approved drugs.

Sleep-Related Variants Show Low Penetrance in Large Population Analysis

A limited number of variants had documented sleep effects in an investigation in PLOS Genetics of 10 genes with reported sleep ties in nearly 192,000 participants in four population studies.

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.